In the area of PK-C inhibitors our synthetic strategy of constraining the diacylglycerol backbone into more complicated structures with specifically oriented pharmacophores has yielded stable synthetic compounds with affinities of 10 nM, already in the range of phorbol esters. Using a chiral 4,4-disubstituted heptono-1,4-lactone template we have reduced the entropy penalty associated with the poor binding of DAG. This template is currently being modified using a receptor-guided approach based on the latest crystallographic data of a phorbol ester bound to one of the zinc-finger regions of PK-Cdelta. When the rigid DAG analogues are docked at the phorbol site, two modes of binding appear theoretically possible. In order to elucidate the correct mode of binding, a series of compounds where key pharmacophores are systematically omitted have been synthesized. Preliminary results favor a particular mode of binding which will guide future molecular modifications to obtain isozyme-specific PK-C activators. A bicyclic heterocyclic ring designed with the aid of a computer algorithm (SPROUT) that fills the gaps between spatially oriented pharmacophores has recently been synthesized. The compound has a respectable Ki in the low micromolar range and it represents a lead compound for the synthesis of related analogues. The hydrolytically resistant beta-methylene analogue of thiazole-4-carboxamide adenine dinucleotide (TAD), the active metabolite of the oncolytic C-nucleoside tiazofurin, is very stable and capable of producing the desired depletion of guanine nucleotide pools even in an experimentally induced tiazofurin-resistant tumor variant. The original synthesis of beta-methylene-TAD was inconvenient and required the use of anion exchange chromatography. With the intent of working with organic soluble intermediates, and aiming at releasing the final polar product at the end of the synthesis, we have employed the Mitsunobu reaction to couple the corresponding nucleosides with a partially protected pyrophosphonate moiety. Formation of phosphonic acid esters with 2',3'-isopropylidene 6-N-benzoyladenosine and 2',3'-isopropylidene tiazofurin worked well under Mitsunobu conditions to give two different halves of the molecule, which were then assembled together.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC006176-11
Application #
2463713
Study Section
Special Emphasis Panel (LMC)
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kikuchi, Junko; Takashina, Taichi; Kinoshita, Ichiro et al. (2012) Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 78:138-43
Comin, Maria J; Czifra, Gabriella; Kedei, Noemi et al. (2009) Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengths. J Med Chem 52:3274-83
Byun, Hyang-Min; Choi, Si Ho; Laird, Peter W et al. (2008) 2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1. Cancer Lett 266:238-48
Yoo, Christine B; Valente, Rocco; Congiatu, Costantino et al. (2008) Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine. J Med Chem 51:7593-601
Philosof-Mazor, Liron; Volinsky, Roman; Comin, Maria J et al. (2008) Self-assembly and lipid interactions of diacylglycerol lactone derivatives studied at the air/water interface. Langmuir 24:11043-52
Ludek, Olaf R; Schroeder, Gottfried K; Wolfenden, Richard et al. (2008) Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase. Nucleic Acids Symp Ser (Oxf) :659-60
Malolanarasimhan, Krishnan; Kedei, Noemi; Sigano, Dina M et al. (2007) Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups. J Med Chem 50:962-78
Kang, Ji-Hye; Benzaria, Samira; Sigano, Dina M et al. (2006) Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions. J Med Chem 49:3185-203
Lee, Jeewoo; Kang, Ji-Hye; Han, Kee-Chung et al. (2006) Branched diacylglycerol-lactones as potent protein kinase C ligands and alpha-secretase activators. J Med Chem 49:2028-36
Kang, Ji-Hye; Peach, Megan L; Pu, Yongmei et al. (2005) Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C. J Med Chem 48:5738-48

Showing the most recent 10 out of 36 publications